Stockscreener 앱 받기
10.92
1.11%
0.12
시간 외 거래:
10.92
전일 마감가:
$10.80
열려 있는:
$10.86
하루 거래량:
722.04K
Relative Volume:
1.29
시가총액:
$495.97M
수익:
$159.01M
순이익/손실:
$-21.72M
주가수익비율:
-21.00
EPS:
-0.52
순현금흐름:
$-20.63M
1주 성능:
+0.28%
1개월 성능:
-33.46%
6개월 성능:
-26.76%
1년 성능:
+55.11%
1일 변동 폭
$10.78
$11.23
1주일 범위
$10.65
$11.47
52주 변동 폭
$6.59
$21.00
Axogen Inc Stock (AXGN) Company Profile
명칭
Axogen Inc
전화
(386) 462-6817
주소
13631 PROGRESS BLVD., ALACHUA, FL
AXGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
10.92 | 495.97M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-17 | 개시 | Lake Street | Buy |
| 2024-07-01 | 개시 | Raymond James | Outperform |
| 2022-11-11 | 재개 | Jefferies | Buy |
| 2022-05-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 개시 | Guggenheim | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | 개시 | Canaccord Genuity | Buy |
| 2018-03-02 | 재확인 | Lake Street | Buy |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2017-11-30 | 개시 | Jefferies | Buy |
| 2017-11-21 | 재확인 | Lake Street | Buy |
| 2017-07-31 | 개시 | Leerink Partners | Outperform |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-06 | 개시 | ROTH Capital | Buy |
| 2016-11-22 | 업그레이드 | Lake Street | Hold → Buy |
| 2016-11-07 | 재확인 | Wedbush | Outperform |
| 2016-11-03 | 다운그레이드 | Lake Street | Buy → Hold |
| 2016-08-04 | 재확인 | Wedbush | Outperform |
| 2014-05-14 | 개시 | Dawson James | Buy |
| 2013-10-31 | 재확인 | Ladenburg Thalmann | Buy |
모두보기
Axogen Inc 주식(AXGN)의 최신 뉴스
AxoGen, Inc. (NASDAQ:AXGN) Sees Significant Increase in Short Interest - Defense World
AxoGen FY2025 EPS Estimate Decreased by Cantor Fitzgerald - Defense World
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In AxoGen, Inc. To Contact The Firm - ACCESS Newswire
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Nuveen Asset Management LLC - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Receives $22.20 Average Price Target from Analysts - Defense World
Millennium Management LLC Lowers Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
ProShare Advisors LLC Invests $197,000 in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
BNP Paribas Financial Markets Has $102,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Jane Street Group LLC Sells 30,670 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference - GlobeNewswire
Bank of America Corp DE Reduces Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Nigeria
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com Australia
Ameriprise Financial Inc. Has $4.81 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Insider Sell: Joseph Tyndall Sells 2,525 Shares of Axogen Inc (A - GuruFocus
Nerve Regeneration Market Deep Research Report with Forecast - openPR.com
AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
How To Trade (AXGN) - news.stocktradersdaily.com
Northern Trust Corp Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
The Manufacturers Life Insurance Company Sells 1,016 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Study Evaluating AxoGen Nerve Graft Complete - Medical Product Outsourcing
Canaccord Genuity Group Has Lowered Expectations for AxoGen (NASDAQ:AXGN) Stock Price - Defense World
Tower Research Capital LLC TRC Sells 1,087 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Nerve Wrap Market Size & Share | Industry Report, 2030 - Grand View Research
Cantor Fitzgerald Reduces Earnings Estimates for AxoGen - Defense World
Axogen (AXGN) Sees Price Target Reduction by Canaccord Genuity | - GuruFocus
Canaccord Adjusts AxoGen (AXGN) Price Target Following Q1 Updates | AXGN Stock News - GuruFocus
What Analysts Are Saying About Axogen Stock - Benzinga
Canaccord Adjusts AxoGen (AXGN) Price Target Following Q1 Update - GuruFocus
Price T Rowe Associates Inc. MD Has $574,000 Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen stock target cut to $24 by Canaccord Genuity - Investing.com South Africa
AxoGen, Inc. (NASDAQ:AXGN) Q1 2025 Earnings Call Transcript - Insider Monkey
(AXGN) Long Term Investment Analysis - news.stocktradersdaily.com
Axogen, Inc. (NASDAQ:AXGN) Might Not Be As Mispriced As It Looks After Plunging 32% - simplywall.st
Axogen, Inc.'s (NASDAQ:AXGN) Intrinsic Value Is Potentially 87% Above Its Share Price - Yahoo Finance
Dimensional Fund Advisors LP Raises Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen’s Earnings Call: Growth Amid Challenges - TipRanks
Breakeven On The Horizon For Axogen, Inc. (NASDAQ:AXGN) - simplywall.st
Balance Sheet Insights: Axogen Inc (AXGN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Axogen, Inc. Reports 2025 First Quarter Financial Results - GlobeNewswire
AxoGen (NASDAQ:AXGN) Shares Gap Down on Disappointing Earnings - Defense World
Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid ... - Yahoo Finance
Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid ... By GuruFocus - Investing.com Canada
Analysts Set AxoGen, Inc. (NASDAQ:AXGN) Target Price at $22.60 - Defense World
Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid Margin Challenges - GuruFocus
Axogen Reports Strong Q1 2025 Revenue Growth - TipRanks
AxoGen: Q1 Earnings Snapshot - Norwalk Hour
Earnings call transcript: AxoGen posts Q1 2025 loss, stock tumbles premarket - Investing.com
Axogen names Lindsey Hartley as new CFO By Investing.com - Investing.com India
AxoGen Q1 2025 Earnings Call Transcript - MarketBeat
Axogen Inc (AXGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.56%
1.70%
자본화:
|
볼륨(24시간):